{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:15:38Z","timestamp":1776129338289,"version":"3.50.1"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T00:00:00Z","timestamp":1371081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T00:00:00Z","timestamp":1371081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Peripheral biomarkers to diagnose Alzheimer's disease (AD) have not been established. Given parallels between neuron and platelet biology, we hypothesized platelet membrane-associated protein changes may differentiate patients clinically defined with probable AD from noncognitive impaired controls.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Purified platelets, confirmed by flow cytometry were obtained from individuals before fractionation by ultracentrifugation. Following a comparison of individual membrane fractions by SDS-PAGE for general proteome uniformity, equal protein weight from the membrane fractions for five representative samples from AD and five samples from controls were pooled. AD and control protein pools were further divided into molecular weight regions by one-dimensional SDS-PAGE, prior to digestion in gel. Tryptic peptides were analyzed by reverse-phase liquid chromatography coupled to tandem mass spectrometry (LC-MS\/MS). Ionized peptide intensities were averaged for each identified protein in the two pools, thereby measuring relative protein abundance between the two membrane protein pools. Log<jats:sub>2<\/jats:sub>-transformed ratio (AD\/control) of protein abundances fit a normal distribution, thereby permitting determination of significantly changed protein abundances in the AD pool.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>We report a comparative analysis of the membrane-enriched platelet proteome between patients with mild to moderate AD and cognitively normal, healthy subjects. A total of 144 proteins were determined significantly altered in the platelet membrane proteome from patients with probable AD. In particular, secretory (alpha) granule proteins were dramatically reduced in AD. Of these, we confirmed significant reduction of thrombospondin-1 (THBS1) in the AD platelet membrane proteome by immunoblotting. There was a high protein-protein connectivity of proteins in other pathways implicated by proteomic changes to the proteins that define secretory granules.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Depletion of secretory granule proteins is consistent with a preponderance of post-activated platelets in circulation in AD. Significantly changed pathways implicate additional AD-related defects in platelet glycoprotein synthesis, lipid homeostasis, amyloidogenic proteins, and regulators of protease activity, many of which may be useful plasma membrane-expressed markers for AD. This study highlights the utility of LC-MS\/MS to quantify human platelet membrane proteins and suggests that platelets may serve as a source of blood-based biomarkers in neurodegenerative disease.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/alzrt186","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T14:15:29Z","timestamp":1371132929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease"],"prefix":"10.1186","volume":"5","author":[{"given":"Laura E","family":"Donovan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric B","family":"Dammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duc M","family":"Duong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J","family":"Hanfelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan I","family":"Levey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas T","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J","family":"Lah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,13]]},"reference":[{"key":"228_CR1","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K: Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proceedings of the National Academy of Sciences of the United States of America. 1985, 82: 4245-4249. 10.1073\/pnas.82.12.4245.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"228_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW: Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical and Biophysical Research Communications. 1984, 120: 885-890. 10.1016\/S0006-291X(84)80190-4.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"228_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.1899488","volume":"251","author":"V Lee","year":"1991","unstructured":"Lee V, Balin B, Otvos L, Trojanowski J: A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science. 1991, 251: 675-678. 10.1126\/science.1899488.","journal-title":"Science"},{"key":"228_CR4","doi-asserted-by":"publisher","first-page":"14946","DOI":"10.1523\/JNEUROSCI.4305-10.2010","volume":"30","author":"SW Pimplikar","year":"2010","unstructured":"Pimplikar SW, Nixon RA, Robakis NK, Shen J, Tsai L-H: Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis. The Journal of Neuroscience. 2010, 30: 14946-14954. 10.1523\/JNEUROSCI.4305-10.2010.","journal-title":"The Journal of Neuroscience"},{"key":"228_CR5","doi-asserted-by":"publisher","first-page":"6117","DOI":"10.1074\/jbc.M110.167239","volume":"286","author":"JH Herskowitz","year":"2011","unstructured":"Herskowitz JH, Seyfried NT, Gearing M, Kahn RA, Peng J, Levey AI, Lah JJ: Rho Kinase II Phosphorylation of the Lipoprotein Receptor LR11\/SORLA Alters Amyloid-\u03b2 Production. Journal of Biological Chemistry. 2011, 286: 6117-6127. 10.1074\/jbc.M110.167239.","journal-title":"Journal of Biological Chemistry"},{"key":"228_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"O Hansson","year":"2006","unstructured":"Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L: Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. The Lancet Neurology. 2006, 5: 228-234. 10.1016\/S1474-4422(06)70355-6.","journal-title":"The Lancet Neurology"},{"key":"228_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","volume":"2","author":"K Blennow","year":"2003","unstructured":"Blennow K, Hampel H: CSF markers for incipient Alzheimer's disease. The Lancet Neurology. 2003, 2: 605-613. 10.1016\/S1474-4422(03)00530-1.","journal-title":"The Lancet Neurology"},{"key":"228_CR8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1053\/euhj.2000.2515","volume":"22","author":"S Kamath","year":"2001","unstructured":"Kamath S, Blann AD, Lip GYH: Platelet activation: assessment and quantification. European Heart Journal. 2001, 22: 1561-1571. 10.1053\/euhj.2000.2515.","journal-title":"European Heart Journal"},{"key":"228_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1423-0410.2005.00618.x","volume":"88","author":"R Cardigan","year":"2005","unstructured":"Cardigan R, Turner C, Harrison P: Current methods of assessing platelet function: relevance to transfusion medicine. Vox Sanguinis. 2005, 88: 153-163. 10.1111\/j.1423-0410.2005.00618.x.","journal-title":"Vox Sanguinis"},{"key":"228_CR10","doi-asserted-by":"publisher","first-page":"e7627","DOI":"10.1371\/journal.pone.0007627","volume":"4","author":"AH Qureshi","year":"2009","unstructured":"Qureshi AH, Chaoji V, Maiguel D, Faridi MH, Barth CJ, Salem SM, Singhal M, Stoub D, Krastins B, Ogihara M, Zaki MJ, Gupta V: Proteomic and Phospho-Proteomic Profile of Human Platelets in Basal, Resting State: Insights into Integrin Signaling. PLoS One. 2009, 4: e7627-10.1371\/journal.pone.0007627.","journal-title":"PLoS One"},{"key":"228_CR11","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1172\/JCI27196","volume":"115","author":"M Gawaz","year":"2005","unstructured":"Gawaz M, Langer H, May AE: Platelets in inflammation and atherogenesis. The Journal of Clinical Investigation. 2005, 115: 3378-3384. 10.1172\/JCI27196.","journal-title":"The Journal of Clinical Investigation"},{"key":"228_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/09537100903047752","volume":"20","author":"FS Kaneez","year":"2009","unstructured":"Kaneez FS, Saeed SA: Investigating GABA and its function in platelets as compared to neurons. Platelets. 2009, 20: 328-333. 10.1080\/09537100903047752.","journal-title":"Platelets"},{"key":"228_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00221-007-1133-7","volume":"183","author":"K Fatima Shad","year":"2007","unstructured":"Fatima Shad K, Saeed S: The metabolism of serotonin in neuronal cells in culture and platelets. Experimental Brain Research. 2007, 183: 411-416. 10.1007\/s00221-007-1133-7.","journal-title":"Experimental Brain Research"},{"key":"228_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0092-8674(03)01014-6","volume":"115","author":"DJ Walther","year":"2003","unstructured":"Walther DJ, Peter J-U, Winter S, H\u00f6ltje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G, Bader M: Serotonylation of Small GTPases Is a Signal Transduction Pathway that Triggers Platelet \u00b1-Granule Release. Cell. 2003, 115: 851-862. 10.1016\/S0092-8674(03)01014-6.","journal-title":"Cell"},{"key":"228_CR15","doi-asserted-by":"crossref","first-page":"15977","DOI":"10.1016\/S0021-9258(18)55493-4","volume":"265","author":"AI Bush","year":"1990","unstructured":"Bush AI, Martins RN, Rumble B, Moir R, Fuller S, Milward E, Currie J, Ames D, Weidemann A, Fischer P: The amyloid precursor protein of Alzheimer's disease is released by human platelets. Journal of Biological Chemistry. 1990, 265: 15977-15983.","journal-title":"Journal of Biological Chemistry"},{"key":"228_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3109\/09537104.2011.593654","volume":"23","author":"P JAREMO","year":"2012","unstructured":"JAREMO P, MILOVANOVIC M, BULLER C, NILSSON S, WINBLAD B: Low-density platelet populations demonstrate low in vivo activity in sporadic Alzheimer disease. Platelets. 2012, 23: 116-120. 10.3109\/09537104.2011.593654.","journal-title":"Platelets"},{"key":"228_CR17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/039463201102400229","volume":"24","author":"A Vignini","year":"2011","unstructured":"Vignini A, Sartini D, Morganti S, Nanetti L, Luzzi S, Provinciali L, Mazzanti L, Emanuelli M: Platelet amyloid precursor protein isoform expression in Alzheimer's disease: evidence for peripheral marker. Int J Immunopathol Pharmacol. 2011, 24: 529-534.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"228_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jns.2005.09.002","volume":"240","author":"K Tang","year":"2006","unstructured":"Tang K, Hynan LS, Baskin F, Rosenberg RN: Platelet amyloid precursor protein processing: A bio-marker for Alzheimer's disease. Journal of the neurological sciences. 2006, 240: 53-58. 10.1016\/j.jns.2005.09.002.","journal-title":"Journal of the neurological sciences"},{"key":"228_CR19","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1038\/jcbfm.2010.140","volume":"30","author":"K Stellos","year":"2010","unstructured":"Stellos K, Panagiota V, Kogel A, Leyhe T, Gawaz M, Laske C: Predictive value of platelet activation for the rate of cognitive decline in Alzheimer\/'s disease patients. J Cereb Blood Flow Metab. 2010, 30: 1817-1820. 10.1038\/jcbfm.2010.140.","journal-title":"J Cereb Blood Flow Metab"},{"key":"228_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1212\/WNL.0b013e3182074bd2","volume":"76","author":"CI Prodan","year":"2011","unstructured":"Prodan CI, Ross ED, Stoner JA, Cowan LD, Vincent AS, Dale GL: Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease. Neurology. 2011, 76: 247-252. 10.1212\/WNL.0b013e3182074bd2.","journal-title":"Neurology"},{"key":"228_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.neurobiolaging.2005.12.011","volume":"28","author":"G Ciabattoni","year":"2007","unstructured":"Ciabattoni G, Porreca E, Di Febbo C, Di Iorio A, Paganelli R, Bucciarelli T, Pescara L, Del Re L, Giusti C, Falco A, Sau A, Patrono C, Dav\u00ec G: Determinants of platelet activation in Alzheimer's disease. Neurobiology of Aging. 2007, 28: 336-342. 10.1016\/j.neurobiolaging.2005.12.011.","journal-title":"Neurobiology of Aging"},{"key":"228_CR22","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jpsychires.2007.07.017","volume":"42","author":"C Laske","year":"2008","unstructured":"Laske C, Leyhe T, Stransky E, Eschweiler GW, Bueltmann A, Langer H, Stellos K, Gawaz M: Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease. Journal of Psychiatric Research. 2008, 42: 746-751. 10.1016\/j.jpsychires.2007.07.017.","journal-title":"Journal of Psychiatric Research"},{"key":"228_CR23","volume-title":"Curr Vasc Pharmacol","author":"C Laske","year":"2012","unstructured":"Laske C, Sopova K, Stellos K: Platelet Activation in Alzheimer's Disease: From Pathophysiology to Clinical Value. Curr Vasc Pharmacol. 2012"},{"key":"228_CR24","volume-title":"Curr Vasc Pharmacol","author":"K Stellos","year":"2012","unstructured":"Stellos K, Katsiki N, Tatsidou P, Bigalke B, Laske C: Association of Platelet Activation with Vascular Cognitive Impairment: Implications in Dementia Development?. Curr Vasc Pharmacol. 2012"},{"key":"228_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2217\/bmm.09.84","volume":"4","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty M, Lovestone S: Blood-based biomarkers of Alzheimer's disease: challenging but feasible. Biomark Med. 2010, 4: 65-79. 10.2217\/bmm.09.84.","journal-title":"Biomark Med"},{"key":"228_CR26","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nbt1235","volume":"24","author":"N Rifai","year":"2006","unstructured":"Rifai N, Gillette MA, Carr SA: Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotech. 2006, 24: 971-983. 10.1038\/nbt1235.","journal-title":"Nat Biotech"},{"key":"228_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/MOH.0b013e328357010e","volume":"19","author":"JW Rowley","year":"2012","unstructured":"Rowley JW, Schwertz H, Weyrich AS: Platelet mRNA: the meaning behind the message. Current opinion in hematology. 2012, 19: 385-391. 10.1097\/MOH.0b013e328357010e.","journal-title":"Current opinion in hematology"},{"key":"228_CR28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1160\/TH12-03-0153","volume":"108","author":"H Pl\u00e9","year":"2012","unstructured":"Pl\u00e9 H, Maltais M, Corduan A, Rousseau G, Madore F, Provost P: Alteration of the platelet transcriptome in chronic kidney disease. Thrombosis and haemostasis. 2012, 108: 605-10.1160\/TH12-03-0153.","journal-title":"Thrombosis and haemostasis"},{"key":"228_CR29","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1182\/blood-2009-02-203828","volume":"114","author":"U Lewandrowski","year":"2009","unstructured":"Lewandrowski U, Wortelkamp S, Lohrig K, Zahedi RP, Wolters DA, Walter U, Sickmann A: Platelet membrane proteomics: a novel repository for functional research. Blood. 2009, 114: e10-e19. 10.1182\/blood-2009-02-203828.","journal-title":"Blood"},{"key":"228_CR30","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1074\/mcp.M500209-MCP200","volume":"4","author":"J Moebius","year":"2005","unstructured":"Moebius J, Zahedi RP, Lewandrowski U, Berger C, Walter U, Sickmann A: The Human Platelet Membrane Proteome Reveals Several New Potential Membrane Proteins. Molecular & Cellular Proteomics. 2005, 4: 1754-1761. 10.1074\/mcp.M500209-MCP200.","journal-title":"Molecular & Cellular Proteomics"},{"key":"228_CR31","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1074\/mcp.M500084-MCP200","volume":"4","author":"WM Old","year":"2005","unstructured":"Old WM, Meyer-Arendt K, Aveline-Wolf L, Pierce KG, Mendoza A, Sevinsky JR, Resing KA, Ahn NG: Comparison of Label-free Methods for Quantifying Human Proteins by Shotgun Proteomics. Molecular & Cellular Proteomics. 2005, 4: 1487-1502. 10.1074\/mcp.M500084-MCP200.","journal-title":"Molecular & Cellular Proteomics"},{"key":"228_CR32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1182\/blood.V91.1.118","volume":"91","author":"UM Vischer","year":"1998","unstructured":"Vischer UM, Wollheim CB: Purine Nucleotides Induce Regulated Secretion of von Willebrand Factor: Involvement of Cytosolic Ca2+ and Cyclic Adenosine Monophosphate-Dependent Signaling in Endothelial Exocytosis. Blood. 1998, 91: 118-127.","journal-title":"Blood"},{"key":"228_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.canlet.2008.01.007","volume":"263","author":"NT Seyfried","year":"2008","unstructured":"Seyfried NT, Huysentruyt LC, Atwood JA, Xia Q, Seyfried TN, Orlando R: Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approach. Cancer Lett. 2008, 263: 243-252. 10.1016\/j.canlet.2008.01.007.","journal-title":"Cancer Lett"},{"key":"228_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/prca.201100068","volume":"6","author":"LE Donovan","year":"2012","unstructured":"Donovan LE, Higginbotham L, Dammer EB, Gearing M, Rees HD, Xia Q, Duong DM, Seyfried NT, Lah JJ, Levey AI: Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease. PROTEOMICS-Clinical Applications. 2012, 6: 201-211. 10.1002\/prca.201100068.","journal-title":"PROTEOMICS-Clinical Applications"},{"key":"228_CR35","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1021\/pr900251d","volume":"8","author":"P Xu","year":"2009","unstructured":"Xu P, Duong DM, Peng J: Systematical optimization of reverse-phase chromatography for shotgun proteomics. J Proteome Res. 2009, 8: 3944-3950. 10.1021\/pr900251d.","journal-title":"J Proteome Res"},{"key":"228_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1021\/pr025556v","volume":"2","author":"J Peng","year":"2003","unstructured":"Peng J, Elias JE, Thoreen CC, Licklider LJ, Gygi SP: Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC\/LC-MS\/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res. 2003, 2: 43-50. 10.1021\/pr025556v.","journal-title":"J Proteome Res"},{"key":"228_CR37","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1021\/ac702516a","volume":"80","author":"NT Seyfried","year":"2008","unstructured":"Seyfried NT, Xu P, Duong DM, Cheng D, Hanfelt J, Peng J: Systematic approach for validating the ubiquitinated proteome. Anal Chem. 2008, 80: 4161-4169. 10.1021\/ac702516a.","journal-title":"Anal Chem"},{"key":"228_CR38","volume-title":"Journal of Proteome Research","author":"YM Gozal","year":"2009","unstructured":"Gozal YM, Duong DM, Gearing M, Cheng D, Hanfelt J, Funderburk C, Peng J, Lah J, Levey A: Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimers disease. Journal of Proteome Research. 2009"},{"key":"228_CR39","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/prca.200700378","volume":"1","author":"J-Y Zhou","year":"2007","unstructured":"Zhou J-Y, Hanfelt J, Peng J: Clinical proteomics in neurodegenerative diseases. PROTEOMICS-Clinical Applications. 2007, 1: 1342-1350. 10.1002\/prca.200700378.","journal-title":"PROTEOMICS-Clinical Applications"},{"key":"228_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2008","unstructured":"Huang DW, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protocols. 2008, 4: 44-57. 10.1038\/nprot.2008.211.","journal-title":"Nat Protocols"},{"key":"228_CR41","first-page":"49","volume":"63","author":"JG White","year":"1978","unstructured":"White JG, Gerrard JM: Recent advances in platelet structural physiology. Supplementum ad Thrombosis and haemostasis. 1978, 63: 49-60.","journal-title":"Supplementum ad Thrombosis and haemostasis"},{"key":"228_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","volume":"305","author":"A Krogh","year":"2001","unstructured":"Krogh A, Larsson B, von Heijne G, Sonnhammer ELL: Predicting transmembrane protein topology with a hidden markov model: application to complete genomes. J Mol Biol. 2001, 305: 567-580. 10.1006\/jmbi.2000.4315.","journal-title":"J Mol Biol"},{"key":"228_CR43","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1023\/B:NERE.0000023618.35579.7c","volume":"29","author":"SI Kim","year":"2004","unstructured":"Kim SI, Voshol H, van Oostrum J, Hastings TG, Cascio M, Glucksman MJ: Neuroproteomics: expression profiling of the brain's proteomes in health and disease. Neurochem Res. 2004, 29: 1317-1331.","journal-title":"Neurochem Res"},{"key":"228_CR44","doi-asserted-by":"publisher","first-page":"e28527","DOI":"10.1371\/journal.pone.0028527","volume":"6","author":"M Thambisetty","year":"2011","unstructured":"Thambisetty M, Simmons A, Hye A, Campbell J, Westman E, Zhang Y, Wahlund L-O, Kinsey A, Causevic M, Killick R, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lovestone S, the AddNeuroMed consortium: Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease. PLoS One. 2011, 6: e28527-10.1371\/journal.pone.0028527.","journal-title":"PLoS One"},{"key":"228_CR45","doi-asserted-by":"publisher","first-page":"e18850","DOI":"10.1371\/journal.pone.0018850","volume":"6","author":"R Craig-Schapiro","year":"2011","unstructured":"Craig-Schapiro R, Kuhn M, Xiong C, Pickering EH, Liu J, Misko TP, Perrin RJ, Bales KR, Soares H, Fagan AM, Holtzman DM: Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis. PLoS One. 2011, 6: e18850-10.1371\/journal.pone.0018850.","journal-title":"PLoS One"},{"key":"228_CR46","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1111\/j.1582-4934.2008.00434.x","volume":"13","author":"JK Ryu","year":"2009","unstructured":"Ryu JK, McLarnon JG: A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. Journal of Cellular and Molecular Medicine. 2009, 13: 2911-2925. 10.1111\/j.1582-4934.2008.00434.x.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"228_CR47","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1161\/ATVBAHA.107.143479","volume":"27","author":"E Herczenik","year":"2007","unstructured":"Herczenik E, Bouma B, Korporaal SJA, Strangi R, Zeng Q, Gros P, Van Eck M, Van Berkel TJC, Gebbink MFBG, Akkerman J-WN: Activation of Human Platelets by Misfolded Proteins. Arteriosclerosis, Thrombosis, and Vascular Biology. 2007, 27: 1657-1665. 10.1161\/ATVBAHA.107.143479.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"228_CR48","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.neuron.2010.05.014","volume":"66","author":"M Cortes-Canteli","year":"2010","unstructured":"Cortes-Canteli M, Paul J, Norris EH, Bronstein R, Ahn HJ, Zamolodchikov D, Bhuvanendran S, Fenz KM, Strickland S: Fibrinogen and 2-Amyloid Association Alters Thrombosis and Fibrinolysis: A Possible Contributing Factor to Alzheimer's Disease. Neuron. 2010, 66: 695-709. 10.1016\/j.neuron.2010.05.014.","journal-title":"Neuron"},{"key":"228_CR49","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1182\/blood.V87.4.1385.bloodjournal8741385","volume":"87","author":"G Berger","year":"1996","unstructured":"Berger G, Masse J, Cramer E: Alpha-granule membrane mirrors the platelet plasma membrane and contains the glycoproteins Ib, IX, and V. Blood. 1996, 87: 1385-1395.","journal-title":"Blood"},{"key":"228_CR50","doi-asserted-by":"publisher","first-page":"14693","DOI":"10.1074\/jbc.270.24.14693","volume":"270","author":"SC Meyer","year":"1995","unstructured":"Meyer SC, Fox JEB: Interaction of Platelet Glycoprotein V with Glycoprotein Ib-IX Regulates Expression of the Glycoproteins and Binding of von Willebrand Factor to Glycoprotein Ib-IX in Transfected Cells. Journal of Biological Chemistry. 1995, 270: 14693-14699. 10.1074\/jbc.270.24.14693.","journal-title":"Journal of Biological Chemistry"},{"key":"228_CR51","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1182\/blood-2006-05-024091","volume":"109","author":"S-Z Luo","year":"2007","unstructured":"Luo S-Z, Mo X, Afshar-Kharghan V, Srinivasan S, L\u00f3pez JA, Li R: Glycoprotein Ib\u03b1 forms disulfide bonds with 2 glycoprotein Ib\u03b2 subunits in the resting platelet. Blood. 2007, 109: 603-609. 10.1182\/blood-2006-05-024091.","journal-title":"Blood"},{"key":"228_CR52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/JAD-2003-5209","volume":"5","author":"N Jahroudi","year":"2003","unstructured":"Jahroudi N, Schmaier A, Srikanth S, Mahdi F, Lutka FA, Bowser R: Von Willebrand factor promoter targets the expression of amyloid \u03b2 protein precursor to brain vascular endothelial cells of transgenic mice. Journal of Alzheimer's Disease. 2003, 5: 149-158.","journal-title":"Journal of Alzheimer's Disease"},{"key":"228_CR53","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2004.12.020","volume":"120","author":"KS Christopherson","year":"2005","unstructured":"Christopherson KS, Ullian EM, Stokes CCA, Mullowney CE, Hell JW, Agah A, Lawler J, Mosher DF, Bornstein P, Barres BA: Thrombospondins Are Astrocyte-Secreted Proteins that Promote CNS Synaptogenesis. Cell. 2005, 120: 421-433. 10.1016\/j.cell.2004.12.020.","journal-title":"Cell"},{"key":"228_CR54","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1182\/blood-2010-01-265561","volume":"116","author":"W Roberts","year":"2010","unstructured":"Roberts W, Magwenzi S, Aburima A, Naseem KM: Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP\/protein kinase A signaling cascade. Blood. 2010, 116: 4297-4306. 10.1182\/blood-2010-01-265561.","journal-title":"Blood"},{"key":"228_CR55","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.cardiores.2006.05.024","volume":"71","author":"JS Isenberg","year":"2006","unstructured":"Isenberg JS, Wink DA, Roberts DD: Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses. Cardiovascular Research. 2006, 71: 785-793. 10.1016\/j.cardiores.2006.05.024.","journal-title":"Cardiovascular Research"},{"key":"228_CR56","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1182\/blood-2007-06-098392","volume":"111","author":"JS Isenberg","year":"2008","unstructured":"Isenberg JS, Romeo MJ, Yu C, Yu CK, Nghiem K, Monsale J, Rick ME, Wink DA, Frazier WA, Roberts DD: Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide\/cGMP signaling. Blood. 2008, 111: 613-623. 10.1182\/blood-2007-06-098392.","journal-title":"Blood"},{"key":"228_CR57","first-page":"783","volume":"141","author":"L Buee","year":"1992","unstructured":"Buee L, Hof PR, Roberts DD, Delacourte A, Morrison JH, Fillit HM: Immunohistochemical Identification of Thrombospondin in Normal Human Brain and in Alzheimer's Disease. American Journal of Pathology. 1992, 141: 783-788.","journal-title":"American Journal of Pathology"},{"key":"228_CR58","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1538-7836.2012.04640.x","volume":"10","author":"M Horn","year":"2012","unstructured":"Horn M, Bertling A, Brodde MF, M\u00dcLler A, Roth J, Van Aken H, Jurk K, Heilmann C, Peters G, Kehrel BE: Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb\/IIIa. Journal of Thrombosis and Haemostasis. 2012, 10: 647-661. 10.1111\/j.1538-7836.2012.04640.x.","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"228_CR59","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000110069","volume":"25","author":"M Traut","year":"2007","unstructured":"Traut M, Haufe CC, Eismann U, Deppisch RM, Stein G, Wolf G: Increased Binding of Beta-2-Microglobulin to Blood Cells in Dialysis Patients Treated with High-Flux Dialyzers Compared with Low-Flux Membranes Contributed to Reduced Beta-2-Microglobulin Concentrations. Blood Purification. 2007, 25: 432-440. 10.1159\/000110069.","journal-title":"Blood Purification"},{"key":"228_CR60","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1309\/W01Y0B808EMEH12L","volume":"129","author":"J Zhang","year":"2008","unstructured":"Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ: CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases. American Journal of Clinical Pathology. 2008, 129: 526-529. 10.1309\/W01Y0B808EMEH12L.","journal-title":"American Journal of Clinical Pathology"},{"key":"228_CR61","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/pmic.200300470","volume":"3","author":"O Carrette","year":"2003","unstructured":"Carrette O, Demalte I, Scherl A, Yalkinoglu O, Corthals G, Burkhard P, Hochstrasser DF, Sanchez J-C: A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics. 2003, 3: 1486-1494. 10.1002\/pmic.200300470.","journal-title":"Proteomics"},{"key":"228_CR62","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1006\/bbrc.1999.0623","volume":"258","author":"VPS Chauhan","year":"1999","unstructured":"Chauhan VPS, Ray I, Chauhan A, Wisniewski HM: Binding of Gelsolin, a Secretory Protein, to Amyloid \u03b2-Protein. Biochemical and Biophysical Research Communications. 1999, 258: 241-246. 10.1006\/bbrc.1999.0623.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"228_CR63","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1042\/0264-6021:3490077","volume":"349","author":"MH Baumann","year":"2000","unstructured":"Baumann MH, Kallij\u00e4rvi J, Lankinen H, Soto C, Haltia M: Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides. Biochemical Journal. 2000, 349: 77-84. 10.1042\/0264-6021:3490077.","journal-title":"Biochemical Journal"},{"key":"228_CR64","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3233\/JAD-2010-100279","volume":"21","author":"A G\u00fcntert","year":"2010","unstructured":"G\u00fcntert A, Campbell J, Saleem M, O'Brien DP, Thompson AJ, Byers HL, Ward MA, Lovestone S: Plasma Gelsolin is Decreased and Correlates with Rate of Decline in Alzheimer's Disease. Journal of Alzheimer's Disease. 2010, 21: 585-596.","journal-title":"Journal of Alzheimer's Disease"},{"key":"228_CR65","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2174\/138920308786733912","volume":"9","author":"R Bucki","year":"2008","unstructured":"Bucki R, Levental I, Kulakowska A, Janmey PA: Plasma gelsolin: function, prognostic value, and potential therapeutic use. Current Protein & Peptide Science. 2008, 9: 541-551. 10.2174\/138920308786733912.","journal-title":"Current Protein & Peptide Science"},{"key":"228_CR66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3233\/JAD-2011-101950","volume":"25","author":"M Fiala","year":"2011","unstructured":"Fiala M, Mahanian M, Rosenthal M, Mizwicki MT, Tse E, Cho T, Sayre J, Weitzman R, Porter V: MGAT3 mRNA: A Biomarker for Prognosis and Therapy of Alzheimer's Disease by Vitamin D and Curcuminoids. Journal of Alzheimer's Disease. 2011, 25: 135-144.","journal-title":"Journal of Alzheimer's Disease"},{"key":"228_CR67","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.neuroimage.2011.12.076","volume":"60","author":"SA Meda","year":"2012","unstructured":"Meda SA, Narayanan B, Liu J, Perrone-Bizzozero NI, Stevens MC, Calhoun VD, Glahn DC, Shen L, Risacher SL, Saykin AJ, Pearlson GD: A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer's disease in the ADNI cohort. Neuroimage. 2012, 60: 1608-1621. 10.1016\/j.neuroimage.2011.12.076.","journal-title":"Neuroimage"},{"key":"228_CR68","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1471-4159.2010.07070.x","volume":"116","author":"MOW Grimm","year":"2011","unstructured":"Grimm MOW, Kuchenbecker J, Rothhaar TL, Gr\u00f6sgen S, Hundsd\u00f6rfer B, Burg VK, Friess P, M\u00fcller U, Grimm HS, Riemenschneider M, Hartmann T: Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease. Journal of Neurochemistry. 2011, 116: 916-925. 10.1111\/j.1471-4159.2010.07070.x.","journal-title":"Journal of Neurochemistry"},{"key":"228_CR69","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1471-4159.1995.65020717.x","volume":"65","author":"JR Connor","year":"1995","unstructured":"Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt P: A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased Brains. Journal of Neurochemistry. 1995, 65: 717-724.","journal-title":"Journal of Neurochemistry"},{"key":"228_CR70","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2174\/156720509788486527","volume":"6","author":"S Freude","year":"2009","unstructured":"Freude S, Schilbach K, Schubert M: The Role of IGF-1 Receptor and Insulin Receptor Signaling for the Pathogenesis of Alzheimer's Disease: From Model Organisms to Human Disease. Current Alzheimer Research. 2009, 6: 213-223. 10.2174\/156720509788486527.","journal-title":"Current Alzheimer Research"},{"key":"228_CR71","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/biof.157","volume":"37","author":"L Fedrizzi","year":"2011","unstructured":"Fedrizzi L, Carafoli E: Ca2+ dysfunction in neurodegenerative disorders: Alzheimer's disease. BioFactors. 2011, 37: 189-196. 10.1002\/biof.157.","journal-title":"BioFactors"},{"key":"228_CR72","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/JAD-2010-100306","volume":"20","author":"C Supnet","year":"2010","unstructured":"Supnet C, Bezprozvanny I: Neuronal Calcium Signaling, Mitochondrial Dysfunction, and Alzheimer's Disease. Journal of Alzheimer's Disease. 2010, 20: 487-498.","journal-title":"Journal of Alzheimer's Disease"},{"key":"228_CR73","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1126\/science.1213210","volume":"334","author":"S Treusch","year":"2011","unstructured":"Treusch S, Hamamichi S, Goodman JL, Matlack KES, Chung CY, Baru V, Shulman JM, Parrado A, Bevis BJ, Valastyan JS, Han H, Lindhagen-Persson M, Reiman EM, Evans DA, Bennett DA, Olofsson A, DeJager PL, Tanzi RE, Caldwell KA, Caldwell GA, Lindquist S: Functional Links Between A\u03b2 Toxicity, Endocytic Trafficking, and Alzheimer's Disease Risk Factors in Yeast. Science. 2011, 334: 1241-1245. 10.1126\/science.1213210.","journal-title":"Science"},{"key":"228_CR74","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.neuron.2010.09.039","volume":"68","author":"N Hirokawa","year":"2010","unstructured":"Hirokawa N, Niwa S, Tanaka Y: Molecular Motors in Neurons: Transport Mechanisms and Roles in Brain Function, Development, and Disease. Neuron. 2010, 68: 610-638. 10.1016\/j.neuron.2010.09.039.","journal-title":"Neuron"},{"key":"228_CR75","doi-asserted-by":"publisher","first-page":"e1001021","DOI":"10.1371\/journal.pbio.1001021","volume":"9","author":"TL Lewis jr","year":"2011","unstructured":"Lewis TL, Mao T, Arnold DB: A Role for Myosin VI in the Localization of Axonal Proteins. PLoS Biol. 2011, 9: e1001021-10.1371\/journal.pbio.1001021.","journal-title":"PLoS Biol"},{"key":"228_CR76","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.bbalip.2010.03.014","volume":"1801","author":"GP Hooff","year":"2010","unstructured":"Hooff GP, Wood WG, M\u00fcller WE, Eckert GP: Isoprenoids, small GTPases and Alzheimer's disease. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids. 2010, 1801: 896-905. 10.1016\/j.bbalip.2010.03.014.","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids"},{"key":"228_CR77","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/j.1471-4159.1992.tb10994.x","volume":"59","author":"M S\u00f6derberg","year":"1992","unstructured":"S\u00f6derberg M, Edlund C, Alafuzoff I, Kristensson K, Dallner G: Lipid composition in different regions of the brain in Alzheimer's disease\/senile dementia of Alzheimer's type. Journal of Neurochemistry. 1992, 59: 1646-1653. 10.1111\/j.1471-4159.1992.tb10994.x.","journal-title":"Journal of Neurochemistry"},{"key":"228_CR78","doi-asserted-by":"publisher","first-page":"10457","DOI":"10.1074\/jbc.M110.149633","volume":"286","author":"EB Dammer","year":"2011","unstructured":"Dammer EB, Na CH, Xu P, Seyfried NT, Duong DM, Cheng D, Gearing M, Rees H, Lah JJ, Levey AI, Rush J, Peng J: Polyubiquitin Linkage Profiles in Three Models of Proteolytic Stress Suggest the Etiology of Alzheimer Disease. Journal of Biological Chemistry. 2011, 286: 10457-10465. 10.1074\/jbc.M110.149633.","journal-title":"Journal of Biological Chemistry"},{"key":"228_CR79","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000095638","volume":"3","author":"L Arnaud","year":"2006","unstructured":"Arnaud L, Robakis NK, Figueiredo-Pereira ME: It May Take Inflammation, Phosphorylation and Ubiquitination to 'Tangle' in Alzheimer's Disease. Neurodegenerative Diseases. 2006, 3: 313-319. 10.1159\/000095638.","journal-title":"Neurodegenerative Diseases"},{"key":"228_CR80","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/156720506779025242","volume":"3","author":"M Blurton-Jones","year":"2006","unstructured":"Blurton-Jones M, LaFerla FM: Pathways by Which A\u03b2 Facilitates Tau Pathology. Current Alzheimer Research. 2006, 3: 437-448. 10.2174\/156720506779025242.","journal-title":"Current Alzheimer Research"},{"key":"228_CR81","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0092-8674(01)00597-9","volume":"107","author":"J Oh","year":"2001","unstructured":"Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S-i, Itoh Y, Seiki M, Itohara S, Takahashi C, Noda M: The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis. Cell. 2001, 107: 789-800. 10.1016\/S0092-8674(01)00597-9.","journal-title":"Cell"},{"key":"228_CR82","doi-asserted-by":"publisher","first-page":"13221","DOI":"10.1073\/pnas.95.22.13221","volume":"95","author":"C Takahashi","year":"1998","unstructured":"Takahashi C, Sheng Z, Horan TP, Kitayama H, Maki M, Hitomi K, Kitaura Y, Takai S, Sasahara RM, Horimoto A, Ikawa Y, Ratzkin BJ, Arakawa T, Noda M: Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proceedings of the National Academy of Sciences. 1998, 95: 13221-13226. 10.1073\/pnas.95.22.13221.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"228_CR83","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/nn1922","volume":"10","author":"T Muraguchi","year":"2007","unstructured":"Muraguchi T, Takegami Y, Ohtsuka T, Kitajima S, Chandana EPS, Omura A, Miki T, Takahashi R, Matsumoto N, Ludwig A, Noda M, Takahashi C: RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity. Nat Neurosci. 2007, 10: 838-845. 10.1038\/nn1922.","journal-title":"Nat Neurosci"},{"key":"228_CR84","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/35081571","volume":"2","author":"VW Yong","year":"2001","unstructured":"Yong VW, Power C, Forsyth P, Edwards DR: Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci. 2001, 2: 502-511. 10.1038\/35081571.","journal-title":"Nat Rev Neurosci"},{"key":"228_CR85","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/156720511795255982","volume":"8","author":"MT Ferretti","year":"2011","unstructured":"Ferretti MT, Cuello AC: Does a Pro-Inflammatory Process Precede Alzheimer's Disease and Mild Cognitive Impairment?. Current Alzheimer Research. 2011, 8: 164-174. 10.2174\/156720511795255982.","journal-title":"Current Alzheimer Research"},{"key":"228_CR86","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.1523\/JNEUROSCI.16-24-07910.1996","volume":"16","author":"JR Backstrom","year":"1996","unstructured":"Backstrom JR, Lim GP, Cullen MJ, T\u00f6k\u00e9s ZA: Matrix Metalloproteinase-9 (MMP-9) Is Synthesized in Neurons of the Human Hippocampus and Is Capable of Degrading the Amyloid-\u03b2 Peptide (1-40). The Journal of Neuroscience. 1996, 16: 7910-7919.","journal-title":"The Journal of Neuroscience"},{"key":"228_CR87","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.brainres.2011.07.022","volume":"1412","author":"S Zara","year":"2011","unstructured":"Zara S, Rapino M, Sozio P, Di Stefano A, Nasuti C, Cataldi A: Ibuprofen and lipoic acid codrug 1 control Alzheimer's disease progression by down-regulating protein kinase C \u00f9-mediated metalloproteinase 2 and 9 levels in \u03b2-amyloid infused Alzheimer's disease rat model. Brain Research. 2011, 1412: 79-87.","journal-title":"Brain Research"},{"key":"228_CR88","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3233\/JAD-2011-101974","volume":"26","author":"NKH Lim","year":"2011","unstructured":"Lim NKH, Villemagne VL, Soon CPW, Laughton KM, Rowe CC, McLean CA, Masters CL, Evin G, Li Q-X: Investigation of Matrix Metalloproteinases, MMP-2 and MMP-9, in Plasma Reveals a Decrease of MMP-2 in Alzheimer's Disease. Journal of Alzheimer's Disease. 2011, 26: 779-786.","journal-title":"Journal of Alzheimer's Disease"},{"key":"228_CR89","doi-asserted-by":"crossref","first-page":"32167","DOI":"10.1074\/jbc.M003834200","volume":"275","author":"K Bein","year":"2000","unstructured":"Bein K, Simons M: Thrombospondin Type 1 Repeats Interact with Matrix Metalloproteinase 2. Journal of Biological Chemistry. 2000, 275: 32167-32173.","journal-title":"Journal of Biological Chemistry"},{"key":"228_CR90","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.1073\/pnas.91.12.5392","volume":"91","author":"FE Thorngate","year":"1994","unstructured":"Thorngate FE, Raghow R, Wilcox HG, Werner CS, Heimberg M, Elam MB: Insulin promotes the biosynthesis and secretion of apolipoprotein B-48 by altering apolipoprotein B mRNA editing. Proceedings of the National Academy of Sciences. 1994, 91: 5392-5396. 10.1073\/pnas.91.12.5392.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"228_CR91","doi-asserted-by":"publisher","first-page":"6393","DOI":"10.1073\/pnas.93.13.6393","volume":"93","author":"RV Farese","year":"1996","unstructured":"Farese RV, V\u00e9niant MM, Cham CM, Flynn LM, Pierotti V, Loring JF, Traber M, Ruland S, Stokowski RS, Huszar D, Young SG: Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. Proceedings of the National Academy of Sciences. 1996, 93: 6393-6398. 10.1073\/pnas.93.13.6393.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"228_CR92","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s11745-999-0427-z","volume":"34","author":"MB Elam","year":"1999","unstructured":"Elam MB, von Wronski MA, Cagen L, Thorngate F, Kumar P, Heimberg M, Wilcox HG: Apolipoprotein B mRNA editing and apolipoprotein gene expression in the liver of hyperinsulinemic fatty Zucker rats: relationship to very low density lipoprotein composition. Lipids. 1999, 34: 809-816. 10.1007\/s11745-999-0427-z.","journal-title":"Lipids"},{"key":"228_CR93","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI1847","volume":"101","author":"J Boren","year":"1998","unstructured":"Boren J, Lee I, Zhu W, Arnold K, Taylor S, Innerarity TL: Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. The Journal of Clinical Investigation. 1998, 101: 1084-1093. 10.1172\/JCI1847.","journal-title":"The Journal of Clinical Investigation"},{"key":"228_CR94","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1001\/archneur.62.10.noc50112","volume":"62","author":"MA Fishel","year":"2005","unstructured":"Fishel MA, Watson GS, Montine TJ, Wang Q, Green PS, Kulstad JJ, Cook DG, Peskind ER, Baker LD, Goldgaber D, Nie W, Asthana S, Plymate SR, Schwartz MW, Craft S: Hyperinsulinemia provokes synchronous increases in central inflammation and \u03b2-amyloid in normal adults. Arch Neurol. 2005, 62: 1539-1544. 10.1001\/archneur.62.10.noc50112.","journal-title":"Arch Neurol"},{"key":"228_CR95","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.2337\/dc11-0308","volume":"34","author":"ZS Tan","year":"2011","unstructured":"Tan ZS, Beiser AS, Fox CS, Au R, Himali JJ, Debette S, DeCarli C, Vasan RS, Wolf PA, Seshadri S: Association of Metabolic Dysregulation With Volumetric Brain Magnetic Resonance Imaging and Cognitive Markers of Subclinical Brain Aging in Middle-Aged Adults. Diabetes Care. 2011, 34: 1766-1770. 10.2337\/dc11-0308.","journal-title":"Diabetes Care"},{"key":"228_CR96","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1006\/bbrc.1993.1745","volume":"193","author":"A Muraishi","year":"1993","unstructured":"Muraishi A, Capuzzi DM, Tuszynski GP: Binding of Thrombospondin to Human Plasma Lipoproteins. Biochemical and Biophysical Research Communications. 1993, 193: 1145-1151. 10.1006\/bbrc.1993.1745.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"228_CR97","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosissup.2008.05.010","volume":"9","author":"R Takechi","year":"2008","unstructured":"Takechi R, Galloway S, Pallebage-Gamarallage MMS, Mamo JCL: Chylomicron amyloid-beta in the aetiology of Alzheimer's disease. Atherosclerosis Supplements. 2008, 9: 19-25.","journal-title":"Atherosclerosis Supplements"},{"key":"228_CR98","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0049-3848(95)00116-9","volume":"79","author":"M Orth","year":"1995","unstructured":"Orth M, Luley C, Wieland H: Effects of VLDL, chylomicrons, and chylomicron remnants on platelet aggregability. Thrombosis Research. 1995, 79: 297-305. 10.1016\/0049-3848(95)00116-9.","journal-title":"Thrombosis Research"},{"key":"228_CR99","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/01.ATV.14.6.1014","volume":"14","author":"N Xu","year":"1994","unstructured":"Xu N, Ohlin AK, Nilsson A: Chylomicron-induced prothrombin activation and platelet aggregation. Arteriosclerosis, Thrombosis, and Vascular Biology. 1994, 14: 1014-1020. 10.1161\/01.ATV.14.6.1014.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"228_CR100","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1006\/bbrc.1995.2103","volume":"213","author":"M Chen","year":"1995","unstructured":"Chen M, Inestrosa NC, Ross GS, Fernandez HL: Platelets are the primary source of amyloid \u03b2-peptide in human blood. Biochemical and Biophysical Research Communications. 1995, 213: 96-103. 10.1006\/bbrc.1995.2103.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"228_CR101","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.2110384","volume":"248","author":"WE van Nostrand","year":"1990","unstructured":"van Nostrand WE, Schmaier AH, Farrow JS, Cunningham DD: Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein. Science. 1990, 248: 745-748. 10.1126\/science.2110384.","journal-title":"Science"},{"key":"228_CR102","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3109\/09537104.2011.593654","volume":"23","author":"P J\u00e4remo","year":"2012","unstructured":"J\u00e4remo P, Milovanovic M, Buller C, Nilsson S, Winblad B: Low-density platelet populations demonstrate low in vivo activity in sporadic Alzheimer disease. Platelets. 2012, 23: 116-120. 10.3109\/09537104.2011.593654.","journal-title":"Platelets"},{"key":"228_CR103","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0140-6736(04)15900-X","volume":"363","author":"I Casserly","year":"2004","unstructured":"Casserly I, Topol EJ: Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. The Lancet. 2004, 363: 1139-1146. 10.1016\/S0140-6736(04)15900-X.","journal-title":"The Lancet"},{"key":"228_CR104","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nm810","volume":"9","author":"Y Huo","year":"2003","unstructured":"Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K: Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2003, 9: 61-67.","journal-title":"Nat Med"},{"key":"228_CR105","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archneur.66.3.343","volume":"66","author":"EP Helzner","year":"2009","unstructured":"Helzner EP, Luchsinger JA, Scarmeas N, Consentino S, Brickman AM, Glymour MM, Stern Y: Contribution of vascular risk factors to the progression in alzheimer disease. Archives of Neurology. 2009, 66: 343-348. 10.1001\/archneur.66.3.343.","journal-title":"Archives of Neurology"},{"key":"228_CR106","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.clineuro.2008.10.006","volume":"111","author":"F Roselli","year":"2009","unstructured":"Roselli F, Tartaglione B, Federico F, Lepore V, Defazio G, Livrea P: Rate of MMSE score change in Alzheimer's disease: Influence of education and vascular risk factors. Clinical Neurology and Neurosurgery. 2009, 111: 327-330. 10.1016\/j.clineuro.2008.10.006.","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"228_CR107","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1182\/blood-2012-08-450080","volume":"120","author":"PE van der Meijden","year":"2012","unstructured":"van der Meijden PE, Heemskerk JW: Platelet protein shake as playmaker. Blood. 2012, 120: 2931-2932. 10.1182\/blood-2012-08-450080.","journal-title":"Blood"},{"key":"228_CR108","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1093\/nar\/28.18.3442","volume":"28","author":"B Snel","year":"2000","unstructured":"Snel B, Lehmann G, Bork P, Huynen MA: STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Research. 2000, 28: 3442-3444. 10.1093\/nar\/28.18.3442.","journal-title":"Nucleic Acids Research"}],"updated-by":[{"DOI":"10.1186\/s13195-021-00839-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000}}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/alzrt186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/alzrt186\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/alzrt186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:29:09Z","timestamp":1728383349000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/alzrt186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,13]]},"references-count":108,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,6]]}},"alternative-id":["228"],"URL":"https:\/\/doi.org\/10.1186\/alzrt186","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,13]]},"assertion":[{"value":"29 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13195-021-00839-y","URL":"https:\/\/doi.org\/10.1186\/s13195-021-00839-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"32"}}